HIV Vaccine Trials Network

E63970

The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.

Jump to: Surface forms Statements Referenced by

Observed surface forms (1)

Surface form Occurrences
HVTN 1

Statements (45)

Predicate Object
instanceOf HIV vaccine research consortium
clinical trials network
research organization
abbreviation HIV Vaccine Trials Network self-linksurface differs
surface form: HVTN
aimsTo accelerate HIV vaccine development
inform global HIV prevention strategies
collaboratesWith National Institute of Allergy and Infectious Diseases
National Institutes of Health
community organizations
research hospitals
universities
coordinates international trial sites
multinational research teams
emphasis community engagement
data quality
ethical conduct of research
participant safety
field HIV vaccine research
clinical trials
immunology
infectious diseases
focus HIV prevention
preventive HIV vaccines
vaccine safety and efficacy
goal develop effective preventive HIV vaccines
evaluate HIV vaccine candidates in humans
understand immune responses to HIV vaccines
hasParticipantType clinical trial volunteers
clinicians
community representatives
scientists
method multicenter clinical trials
randomized controlled trials
researchArea phase 1 HIV vaccine trials
phase 2 HIV vaccine trials
phase 3 HIV vaccine trials
scope global
studies HIV acquisition rates in trial participants
HIV vaccine immunogenicity
HIV vaccine safety
subjectOf HIV vaccine trial reports
peer-reviewed scientific publications
typeOfOrganization nonprofit research network
uses ICH E6 Good Clinical Practice
surface form: Good Clinical Practice guidelines

standardized clinical trial protocols

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

HIV Vaccine Trials Network abbreviation HIV Vaccine Trials Network self-linksurface differs
this entity surface form: HVTN
Duke Human Vaccine Institute collaboratesWith HIV Vaccine Trials Network